EU-PEARL to participate in the Complex Clinical Trials multi stakeholder workshop organised by EFPIA

Complex Clinical Trials (CCTs) have the potential to accelerate drug development and enable patients to get timely access to transformative therapies. To continue generating innovative shared solutions for the use of CTT, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has organised the virtual workshop “Accelerating Adoption of Complex Clinical Trials in Europe and beyond” next 5th – 6th October. In this multistakeholder forum, EU-PEARL representative, Cecile Spiertz (Janssen) will share the project’s vision and experience so far in co-creating generic frameworks, templates, tools, and the infrastructure to facilitate patient-centric collaborative platform trials.

This hands-on multi-stakeholder workshop will gather scientific experts from Academia, Industry, Ethics Committees, Regulatory and HTA bodies and NGO and patient advocacy groups representatives. The format features use of case examples and interactive sessions to facilitate co-creation of solutions and active contribution by participants.

More information about this event here.

Sign up to stay informed


    We will process your data to deliver our quarterly updates to your inbox. You can view our Privacy Policy here or contact us at info@eu-pearl.eu